TOP PICK
Merging with Merck (MRK-N). Combination will create a very strong pipeline of products, which for many years will have a good growth profile. It will merge short to mid cycle products with longer-term type products and thinks there are significant synergy type benefits. You could also own Merk but this is a discounted way of playing this. (See also MRK-N.)
biotechnology / pharmaceutical

Unlock the latest expert's opinion. Its free

Create a FREE account to see the latest opinions & get alerts about when to buy, sell or hold stocks

Unlock the latest opinion & get signals
DON'T BUY
Smaller US drug manufacturer. Has been hit along with the others. A big wall of branded drugs will be falling off and become generic in 2010 and 2011. Has also had negative news on some of its drug development. Decent pipeline of new drugs. Expecting volatility while leading up to the election. (See Top Picks.)
biotechnology / pharmaceutical
DON'T BUY
Drugs in general have been very poor performers. This company had its fortunes tied to one new drug and that things were happening to it. He can see no catalyst that would make him buy this.
biotechnology / pharmaceutical
TOP PICK
Very well managed but has run into all kinds of problems in the last 3 or 4 months stemming from one of their major products Vitorin, which they market in a joint venture with Merck. If you value the company on sales and you give zero sales to Vitorin, you are getting the same multiple levels as the other pharmaceutical companies. Great pipeline. New drug coming out in May or June to treat paralysis.
biotechnology / pharmaceutical
TOP PICK

(Top Sell) With rising interest rates and high oil prices and slowing earnings growth can create some problems.

biotechnology / pharmaceutical
DON'T BUY
Has been a basket case. Management issues. Could drop further.
biotechnology / pharmaceutical
DON'T BUY
The drug Clariton will be going generic. At fair value now.
biotechnology / pharmaceutical
DON'T BUY
Have had a lot of difficulties. Their drug Clariton came off patent allowing competitors in. The new CEO has a good reputation. Have to see a big improvement in their drug pipeline.
biotechnology / pharmaceutical
DON'T BUY
Prefers Pfizer.
biotechnology / pharmaceutical
BUY
Clariton has moved from a prescription drug in the US to an over the counter one, but their newer drug will be a prescription, meaning larger margins. Possible takeover.
biotechnology / pharmaceutical
BUY
Great sector. Had a tough year. Getting cleaned up now. Good pipeline. Good price.
biotechnology / pharmaceutical
DON'T BUY
Broke through a technical base. Generics are giving some tough competition.
biotechnology / pharmaceutical
TOP PICK
FDA problems have been cleared up. Good pipeline. 21 X earnings.
biotechnology / pharmaceutical
DON'T BUY
FDA has closed their factory at times. Cheap. Could be a buyout. Not a fan.
biotechnology / pharmaceutical
BUY
Good sector to be in.
biotechnology / pharmaceutical
Showing 1 to 15 of 16 entries

Schering Plough Corp(SGP-N) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Schering Plough Corp is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Schering Plough Corp(SGP-N) Frequently Asked Questions

What is Schering Plough Corp stock symbol?

Schering Plough Corp is a OTC stock, trading under the symbol SGP-N on the (). It is usually referred to as or SGP-N

Is Schering Plough Corp a buy or a sell?

In the last year, there was no coverage of Schering Plough Corp published on Stockchase.

Is Schering Plough Corp a good investment or a top pick?

Schering Plough Corp was recommended as a Top Pick by on . Read the latest stock experts ratings for Schering Plough Corp.

Why is Schering Plough Corp stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Schering Plough Corp worth watching?

In the last year 0 stock analysts on Stockchase covered Schering Plough Corp. The stock is worth watching.

What is Schering Plough Corp stock price?

On , Schering Plough Corp (SGP-N) stock closed at a price of $.